FIELD: medicine.
SUBSTANCE: present invention relates to medicine, in particular to an oral pharmaceutical fixed dose composition and its process of preparation for use in the treatment of tuberculosis, wherein said oral pharmaceutical composition comprises: granules comprising isoniazid; granules comprising rifapentine; and at least one extragranular excipient.
EFFECT: implementation of the invention allows producing a chemically stable pharmaceutical fixed dose composition, comprising rifapentine and isoniazid.
11 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN FORM OF DISPERSIBLE TABLET CONTAINING GRANULATED ISONIAZID AND GRANULATED RIFAPENTINE, AND METHOD FOR PREPARING IT | 2014 |
|
RU2694056C2 |
| ANTITUBERCULAR COMPOSITION COMPRISING RIFAMPICIN, ISONIAZID, ETHAMBUTOL AND PYRAZINAMIDE AND PROCESS FOR PREPARATION THEREOF | 2014 |
|
RU2672879C2 |
| SOLID PREPARATIVE FORMS OF OSPEMIFENE | 2005 |
|
RU2423113C2 |
| PHARMACEUTICAL COMPOSITIONS WITH CDC7 INHIBITOR | 2019 |
|
RU2810927C2 |
| SOLID FORMULATIONS OF OSPEMIFENE | 2005 |
|
RU2675624C2 |
| HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIB | 2015 |
|
RU2705156C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR | 2010 |
|
RU2602865C2 |
| CENICRIVIROC COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2014 |
|
RU2633069C2 |
